| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Age-based disparities in treatment and outcomes of retroperitoneal rhabdomyosarcoma
|
Kashtan, Mark A.
|
|
2015
|
21 |
3 |
p. 602-608
|
artikel
|
| 2 |
Anti-PD-L1/PD-1 immune therapies in ovarian cancer: basic mechanism and future clinical application
|
Mandai, Masaki
|
|
2016
|
21 |
3 |
p. 456-461
|
artikel
|
| 3 |
A retrospective analysis on the utility and complications of upper arm ports in 433 cases at a single institute
|
Mori, Yukiko
|
|
2015
|
21 |
3 |
p. 474-482
|
artikel
|
| 4 |
Basics of PD-1 in self-tolerance, infection, and cancer immunity
|
Chikuma, Shunsuke
|
|
2016
|
21 |
3 |
p. 448-455
|
artikel
|
| 5 |
Basics of PD-1 in self-tolerance, infection, and cancer immunity
|
Chikuma, Shunsuke
|
|
|
21 |
3 |
p. 448-455
|
artikel
|
| 6 |
Characterization of mild and severe post-radical nephrectomy renal functional deterioration utilizing histopathological evaluation of non-neoplastic nephrectomized renal parenchyma
|
Sejima, Takehiro
|
|
2015
|
21 |
3 |
p. 588-594
|
artikel
|
| 7 |
Efficacy of aprepitant for the prevention of chemotherapy-induced nausea and vomiting with a moderately emetogenic chemotherapy regimen: a multicenter, placebo-controlled, double-blind, randomized study in patients with gynecologic cancer receiving paclitaxel and carboplatin
|
Yahata, Hideaki
|
|
2015
|
21 |
3 |
p. 491-497
|
artikel
|
| 8 |
Erratum to: Preoperative predictive factors and further risk stratification of biochemical recurrence in clinically localized high-risk prostate cancer
|
Hamada, Riu
|
|
2016
|
21 |
3 |
p. 601
|
artikel
|
| 9 |
Evaluation of the efficacy of palonosetron for prevention of chemotherapy-induced nausea and vomiting in patients with gastric cancer treated with S-1 plus cisplatin
|
Oyama, Katsunobu
|
|
2015
|
21 |
3 |
p. 483-490
|
artikel
|
| 10 |
Gemcitabine in patients previously treated with platinum-containing chemotherapy for refractory thymic carcinoma: radiographic assessment using the RECIST criteria and the ITMIG recommendations
|
Okuma, Yusuke
|
|
2015
|
21 |
3 |
p. 531-538
|
artikel
|
| 11 |
Health insurance status and survival among patients with head and neck cancer in Japan
|
Takenaka, Yukinori
|
|
2015
|
21 |
3 |
p. 517-522
|
artikel
|
| 12 |
Human papillomavirus type-specific persistence and reappearance after successful conization in patients with cervical intraepithelial neoplasia
|
Kudoh, Akiko
|
|
2015
|
21 |
3 |
p. 580-587
|
artikel
|
| 13 |
Incidence and severity of adverse events associated with re-irradiation for spine or pelvic bone metastases
|
Hirano, Yasuhiro
|
|
2015
|
21 |
3 |
p. 609-614
|
artikel
|
| 14 |
Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of ovarian cancer including primary peritoneal cancer and fallopian tube cancer
|
Komiyama, Shinichi
|
|
2016
|
21 |
3 |
p. 435-446
|
artikel
|
| 15 |
Japan Society of Gynecologic Oncology guidelines 2013 for the treatment of uterine body neoplasms
|
Ebina, Yasuhiko
|
|
2016
|
21 |
3 |
p. 419-434
|
artikel
|
| 16 |
Multicenter randomized phase II clinical trial of oxaliplatin reintroduction as a third- or later-line therapy for metastatic colorectal cancer—biweekly versus standard triweekly XELOX (The ORION Study)
|
Matsuda, Chu
|
|
2015
|
21 |
3 |
p. 566-572
|
artikel
|
| 17 |
Outcomes of very elderly patients with aggressive B-cell non-Hodgkin lymphoma treated with reduced-dose chemotherapy
|
Iioka, Futoshi
|
|
2015
|
21 |
3 |
p. 498-505
|
artikel
|
| 18 |
PD-1/PD-L1 blockade in cancer treatment: perspectives and issues
|
Hamanishi, Junzo
|
|
2016
|
21 |
3 |
p. 462-473
|
artikel
|
| 19 |
PD-1/PD-L1 blockage in cancer treatment—from basic research to clinical application
|
Mandai, Masaki
|
|
2016
|
21 |
3 |
p. 447
|
artikel
|
| 20 |
Phase II multi-institutional prospective randomized trial comparing S-1 plus paclitaxel with paclitaxel alone as second-line chemotherapy in S-1 pretreated gastric cancer (CCOG0701)
|
Nakanishi, Koki
|
|
2015
|
21 |
3 |
p. 557-565
|
artikel
|
| 21 |
Preoperative predictive factors and further risk stratification of biochemical recurrence in clinically localized high-risk prostate cancer
|
Hamada, Riu
|
|
2015
|
21 |
3 |
p. 595-600
|
artikel
|
| 22 |
Prognostic impact of a single-nucleotide polymorphism near the CTSO gene in hormone receptor-positive breast cancer patients
|
Hato, Yukari
|
|
2015
|
21 |
3 |
p. 539-547
|
artikel
|
| 23 |
Proposal for selection criteria of secondary cytoreductive surgery in recurrent epithelial ovarian, tubal, and peritoneal cancers
|
Minaguchi, Takeo
|
|
2015
|
21 |
3 |
p. 573-579
|
artikel
|
| 24 |
Sarcopenia as a predictor of major hepatectomy complications: a little addition
|
Cintosun, Umit
|
|
2015
|
21 |
3 |
p. 615
|
artikel
|
| 25 |
Secondary cancers after a childhood cancer diagnosis: a nationwide hospital-based retrospective cohort study in Japan
|
Ishida, Yasushi
|
|
2015
|
21 |
3 |
p. 506-516
|
artikel
|
| 26 |
Stromal markers AKR1C1 and AKR1C2 are prognostic factors in primary human breast cancer
|
Wenners, Antonia
|
|
2015
|
21 |
3 |
p. 548-556
|
artikel
|
| 27 |
Trimodality strategy for treating malignant pleural mesothelioma: results of a feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation (Japan Mesothelioma Interest Group 0601 Trial)
|
Hasegawa, Seiki
|
|
2015
|
21 |
3 |
p. 523-530
|
artikel
|
Tijdschrift beschrijving